[1]
D. Djukić-Ćosić, “Toxicological aspect of immunomodulators: friend or foe in increasing the effectiveness of cancer immunotherapy”, arhfarm, vol. 72, no. Suppl. 4, pp. S167-S168, Oct. 2022, Accessed: Jul. 12, 2026. [Online]. Available: https://asistent.ceon.rs/index.php/arhfarm/article/view/38633